Atnaujinkite slapukų nuostatas

Immunization Safety Review: Influenza Vaccines and Neurological Complications [Minkštas viršelis]

  • Formatas: Paperback / softback, 190 pages, aukštis x plotis x storis: 229x152x13 mm, weight: 318 g
  • Išleidimo metai: 20-Feb-2004
  • Leidėjas: National Academies Press
  • ISBN-10: 0309090865
  • ISBN-13: 9780309090865
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 190 pages, aukštis x plotis x storis: 229x152x13 mm, weight: 318 g
  • Išleidimo metai: 20-Feb-2004
  • Leidėjas: National Academies Press
  • ISBN-10: 0309090865
  • ISBN-13: 9780309090865
Kitos knygos pagal šią temą:
Infection with the influenza virus can have a serious effect on the health of people of all ages, although it is particularly worrisome for infants, the elderly, and people with underlying heart or lung problems. A vaccine exists (the a /flua shot) that can greatly decrease the impact of influenza. Because the strains of virus that are expected to cause serious illness and death are slightly different every year, the vaccine is also slightly different every year and it must be given every year, unlike other vaccines. The Immunization Safety Review committee reviewed the data on influenza vaccine and neurological conditions and concluded that the evidence favored rejection of a causal relationship between influenza vaccines and exacerbation of multiple sclerosis. For the other neurological conditions studied, the committee concluded the evidence about the effects of influenza vaccine is inadequate to accept or reject a causal relationship. The committee also reviewed theories on how the influenza vaccine could damage the nervous system. The evidence was at most weak that the vaccine could act in humans in ways that could lead to these neurological problems.
Executive Summary
1(22)
Immunization Safety Review: Influenza Vaccines and Neurological Complications
23(132)
The Charge to the Committee
23(2)
The Study Process
25(1)
The Framework for Scientific Assessment
25(6)
Under Review: Influenza Vaccines and Neurological Complications
31(13)
Scientific Assessment
44(87)
Significance Assessment
131(9)
Recommendations for Public Health Response
140(7)
References
147(8)
Appendix A 155(13)
Appendix B 168(2)
Appendix C 170(5)
Appendix D 175
Kathleen Stratton, Donna A. Alamario, Theresa Wizemann, and Marie C. McCormick, Editors, Immunization Safety Review Committee